ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,146.86
-0.21%
Dow Jones
38,589.16
-0.15%
Gold vs US Dollar
2,324.45
-0.37%
Brent Oil
81.985
-0.17%
Bitcoin
66,338.43
-0.46%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC
  6. Capstone Therapeutics Corporation (QB) (CAPS)

  7. Capstone Therapeutics Corporation (QB) (CAPS) News

Capstone Therapeutics (QB) (CAPS)

Capstone Therapeutics Corporation (QB)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:CAPS
DateTimeSourceHeadlineSymbolCompany
25/09/201921:01Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)USOTC:CAPSCapstone Therapeutics Corporation (QB)
09/09/201914:02Edgar (US Regulatory)Amended Statement of Ownership: Private Transaction (sc 13e3/a)USOTC:CAPSCapstone Therapeutics Corporation (QB)
26/08/201921:00Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CAPSCapstone Therapeutics Corporation (QB)
20/08/201922:25Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:CAPSCapstone Therapeutics Corporation (QB)
13/08/201914:02Edgar (US Regulatory)Quarterly Report (10-q)USOTC:CAPSCapstone Therapeutics Corporation (QB)
10/07/201921:02Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:CAPSCapstone Therapeutics Corporation (QB)
03/07/201919:52Edgar (US Regulatory)Amended Statement of Ownership: Private Transaction (sc 13e3/a)USOTC:CAPSCapstone Therapeutics Corporation (QB)
03/07/201919:41Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)USOTC:CAPSCapstone Therapeutics Corporation (QB)
31/05/201921:48Edgar (US Regulatory)Statement of Ownership: Private Transaction (sc 13e3)USOTC:CAPSCapstone Therapeutics Corporation (QB)
31/05/201921:04Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)USOTC:CAPSCapstone Therapeutics Corporation (QB)
13/05/201917:03Edgar (US Regulatory)Quarterly Report (10-q)USOTC:CAPSCapstone Therapeutics Corporation (QB)
22/03/201920:04Edgar (US Regulatory)Annual Report (10-k)USOTC:CAPSCapstone Therapeutics Corporation (QB)
21/03/201913:03Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)USOTC:CAPSCapstone Therapeutics Corporation (QB)
21/03/201913:03Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)USOTC:CAPSCapstone Therapeutics Corporation (QB)
21/03/201913:03Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)USOTC:CAPSCapstone Therapeutics Corporation (QB)
21/03/201913:02Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)USOTC:CAPSCapstone Therapeutics Corporation (QB)
19/03/201921:02Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:CAPSCapstone Therapeutics Corporation (QB)
19/03/201920:01Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CAPSCapstone Therapeutics Corporation (QB)
13/02/201921:46Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:CAPSCapstone Therapeutics Corporation (QB)
11/02/201918:02Edgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:CAPSCapstone Therapeutics Corporation (QB)
04/02/201920:53Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:CAPSCapstone Therapeutics Corporation (QB)
28/12/201817:38Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:CAPSCapstone Therapeutics Corporation (QB)
20/11/201822:25Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:CAPSCapstone Therapeutics Corporation (QB)
06/11/201820:33Edgar (US Regulatory)Quarterly Report (10-q)USOTC:CAPSCapstone Therapeutics Corporation (QB)
13/08/201821:04Edgar (US Regulatory)Quarterly Report (10-q)USOTC:CAPSCapstone Therapeutics Corporation (QB)
18/05/201822:02Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:CAPSCapstone Therapeutics Corporation (QB)
11/05/201821:03Edgar (US Regulatory)Quarterly Report (10-q)USOTC:CAPSCapstone Therapeutics Corporation (QB)
07/05/201814:02Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CAPSCapstone Therapeutics Corporation (QB)
28/02/201821:04Edgar (US Regulatory)Annual Report (10-k)USOTC:CAPSCapstone Therapeutics Corporation (QB)
01/02/201823:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:CAPSCapstone Therapeutics Corporation (QB)
 Showing the most relevant articles for your search:USOTC:CAPS

Your Recent History

LSE
RBD
Reabold Resources
LSE
CPL
LSE
SVE
Starvest
LSE
TW.
Taylor Wimpey
LSE
ESO
Epe Special Opportunities
LSE
GKP
Gulf Keystone Petroleum
LSE
HE1
Helium One Global
LSE
SQZ
Serica Energy
LSE
XPF
Xp Factory
LSE
KMK
Kromek
LSE
IQG
Iqgeo
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved